Stockscreener 앱 받기
113.17
2.38%
2.63
시장 영업 전:
114.40
1.23
+1.09%
Revvity Inc 주식(RVTY)의 최신 뉴스
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Revvity Announces Development of High-Throughput T-SPOT.TB Automated Platform for Clinical Labs - FinancialContent
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity, Inc. (RVTY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Revvity, Inc. (RVTY) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Insider Sell Alert: Anita Gonzales Sells Shares of Revvity Inc (RVTY) - GuruFocus
How Revvity’s (RVTY) Startup Software Push and ESG Disclosures Reframe Its Competitive Positioning - simplywall.st
Revvity to Launch Signals for Startups for Emerging Biotech Companies - The Globe and Mail
Revvity Inc. Stock Slides 3.4%, Underperforms Peers - webull.com
Revvity stock holds steady as Q1 2026 growth and margin expansion underpin valuation - Ad-hoc-news.de
Precision Trading with Revvity Inc. (RVTY) Risk Zones - Stock Traders Daily
Revvity Inc (RVTY) Stock Down 3.4% -- Now Undervalued? GF Score: 72/100 - GuruFocus
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Revvity Launches “Signals for Startups” to Help Emerging Biotechs Build Scalable Digital Foundations from Day One - 01net
RVTY (RVTY) investor files notice to sell 85 common shares - Stock Titan
Revvity (NYSE: RVTY) removes 1.875% notes due 2026 from NYSE listing - Stock Titan
Revvity launches “Signals for Startups” to give emerging biotechs an enterprise-grade digital edge - Indian Chemical News
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions Disclosure - Lelezard
Revvity stock trades steadily as recent earnings highlight margin focus - Ad-hoc-news.de
PKI5144059 Bond Coupon Profile — Rate & Payments - TradingView
Revvity (NYSE: RVTY) VP Gonzales sells 85 shares under 10b5-1 plan - Stock Titan
PKI5144059 Bond Profile — Key Metrics - TradingView
XS1405780617 Bond Coupon Profile — Rate & Payments - TradingView
XS1405780617 Bond Risk Profile - TradingView
PKI5255604 Bond Risk Profile - TradingView
XS1405780617 Bond Profile — Key Metrics - TradingView
Revvity stock trades steady as genomics and diagnostics revenue underpins valuation - Ad-hoc-news.de
Revvity, Inc. (PKN) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Revvity, Inc. (PKN) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
PKI5255604 Bond Profile — Key Metrics - TradingView
PKI5255604 Bond Coupon Profile — Rate & Payments - TradingView
Revvity stock trades steadily as recent earnings highlight growth and margin pressure - Ad-hoc-news.de
Revvity Inc. stock outperforms competitors on strong trading day - MSN
Revvity (RVTY) Q4 2025 earnings summary - Quartr
TD Cowen Adjusts Price Target on Revvity to $130 From $120, Maintains Buy Rating - marketscreener.com
REVVITY INC : TD COWEN RAISES TARGET PRICE TO $130 FROM $120 - Moomoo
TD Cowen Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $130 - Moomoo
Revvity (RVTY) Investor Day 2024 Summary - Quartr
Revvity (RVTY) TD Cowen 46th Annual Health Care Conference Summary - Quartr
Revvity (RVTY) Citi Annual Global Healthcare Conference 2025 Summary - Quartr
PKI4882935 Bond Risk Profile - TradingView
A184AM Bond Risk Profile - TradingView
A184AM Bond Coupon Profile — Rate & Payments - TradingView
S&P Global upgrades Revvity outlook on leverage improvement By Investing.com - Investing.com Nigeria
A184AM Bond Profile — Key Metrics - TradingView
PKI5255603 Bond Profile — Key Metrics - TradingView
S&P Global upgrades Revvity outlook on leverage improvement - Investing.com
Revvity: Overvalued On Sentiment (NYSE:RVTY) - Seeking Alpha
The path to AI federated learning for drug discovery - Scientific Computing World
Baird Adjusts Price Target on Revvity to $128 From $117, Maintains Outperform Rating - marketscreener.com
Revvity, Inc. Stock 12‑Month Price Target Raised to $116.07, Implies 3% Upside - TradingView
Revvity, Inc. (RVTY) Stock Analysis: Navigating Growth with a 7% Revenue Rise and Analyst Insights - DirectorsTalk Interviews
ETFs Investing in Revvity, Inc. Stocks - TradingView
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity expands Signals AI with Anthropic Claude integration - MSN
Should Revvity’s (RVTY) Claude Integration Reframe How Investors View Its Data and AI Strategy? - Yahoo Finance
Revvity Inc (RVTY) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Revvity (RVTY) Joins Anthropic Directory To Bring Claude Into Signals Research Workflows - Yahoo Finance
Revvity Inc. focuses on life sciences tools as investors watch fundamentals - Ad-hoc-news.de
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Revvity to announce Q2 2026 results on August 4 - scanx.trade
Press Release: Revvity to Hold Earnings Call on Tuesday, August 4, 2026 - Moomoo
Revvity to Hold Earnings Call on Tuesday, August 4, 2026 - Business Wire
Revvity Inc. outlines its life sciences focus as a diversified tools provider - Ad-hoc-news.de
Revvity Inc. outlines its life sciences focus as investors track its Nasdaq listing - ad-hoc-news.de
8.61%
자본화:
|
볼륨(24시간):